Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Still can't believe
View:
Post by Forestview on Jan 12, 2021 2:42pm

Still can't believe

This company is posed for Phase 3 on a groundbreaking drug, and the market cap is only $160M.  

Ridiculous.
Comment by Layth1990 on Jan 12, 2021 2:55pm
partnering with big pharma and nasdaq listing will make this fly.
Comment by Marky1 on Jan 12, 2021 3:02pm
WHEN? 
Comment by themagicbox on Jan 12, 2021 3:16pm
Anyones guess Marky. This is the 'wild card' factor. Like MUGS was saying, this corporate update was definitely not "comprehensive". Classic Dan imo, ugh. More optimistic now that Haut and Stauffer are on board though. Dead money for now as there are no short term catalysts that I see. This is important to mention so that people are not bag holding, and can make more money ...more  
Comment by HarveyTwoface on Jan 12, 2021 3:30pm
Think positive: whoever wants a deal for China, Latin America, Russia or India need to act quickly before Biggest Pharma enters the stage or their price for a deal will be higher than what they need to pay now... that's what I am hoping for at the moment. And huge investors (there are private investors with deep pockets) can still easily buy a huge chunk for great returns in the near future ...more  
Comment by themagicbox on Jan 12, 2021 3:36pm
Fingers crossed, Harvey. 
Comment by MrMugsy on Jan 12, 2021 3:44pm
------- Agreed ... it's frustrating. But we're now entering a place we've never been before - we're negotiating with various companies and we know that ATE doesn't want to go into Phase 3 on its own. We also know the family of drugs are impressive so it should get attention from many parties. The rest if rather blurry ... hahaha!
Comment by Layth1990 on Jan 12, 2021 4:50pm
I have no idea but i'm optimistic. My mind telling me this will explode all of a second. big pharma for partnering, That will push the price to 6 then followed by nasdaq listing. we will sit around 8cad before phase 3 and 12 during phase 3. If Results are successfull, we wont even have a chance to check it out ,we get bought around 50cad/share. it is worth the wait! I have ate in my tfsa ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities